Ligand Pharma Stock Price, News & Analysis
Company Description
Ligand Pharma (OTC Link: LGNYZ) is a publicly traded company.
LGNYZ stock has gained 117.0% over the past year. Shares last traded at $0.0689.
On a trailing twelve-month basis, Ligand Pharma reported revenue of $268.1M with net income of $124.5M and diluted earnings per share of $6.13. The company operates at a net profit margin of 46.4%.
This page provides a comprehensive overview of LGNYZ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ligand Pharma (LGNYZ) stock last traded at $0.0689. Over the past 12 months, the stock has gained 117.0%.
Latest News
SEC Filings
Ligand Pharma has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LGNYZ SEC filings →
Financial Highlights
Ligand Pharma generated $268.1M in revenue over the trailing twelve months, operating income reached $41.0M (15.3% operating margin), and net income was $124.5M, reflecting a 46.4% net profit margin. Diluted earnings per share stood at $6.13. The company generated $49.4M in operating cash flow. With a current ratio of 22.23, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ligand Pharma (LGNYZ) currently stands at 2.1 thousand shares. Over the past 12 months, short interest has decreased by 85.8%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Ligand Pharma (LGNYZ) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 96986.4% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.